Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation
暂无分享,去创建一个
[1] G. Gullo,et al. Oncofertility and Reproductive Counseling in Patients with Breast Cancer: A Retrospective Study , 2022, Journal of clinical medicine.
[2] A. Coomarasamy,et al. Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis , 2022, Human reproduction update.
[3] A. Lanes,et al. Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation , 2022, Reproductive Biology and Endocrinology.
[4] F. Gumy-Pause,et al. Pregnancy and pregnancy outcomes after hematopoietic stem cell transplantation in childhood: a cross-sectional survey of the EBMT Pediatric Diseases Working Party. , 2021, Human reproduction.
[5] E. Bosch,et al. Individualized luteal phase support normalizes live birth rate in women with low progesterone levels on the day of embryo transfer in artificial endometrial preparation cycles. , 2021, Fertility and sterility.
[6] A. Karger,et al. Cancer and Relationship Dissolution: Perspective of Partners of Cancer Patients , 2021, Frontiers in Psychology.
[7] M. Weintraub,et al. Chemotherapy-based gonadotoxicity risk evaluation as a predictor of reproductive outcomes in post-pubertal patients following ovarian tissue cryopreservation , 2021, BMC Women's Health.
[8] C. Stern,et al. Ovarian tissue grafting: Lessons learnt from our experience with 55 grafts , 2021, Reproductive medicine and biology.
[9] A. Pellicer,et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers. , 2021, Fertility and sterility.
[10] J. Remohi,et al. Oocyte vitrification for fertility preservation for both medical and nonmedical reasons. , 2021, Fertility and sterility.
[11] N. Frydman,et al. Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience , 2021, Journal of Assisted Reproduction and Genetics.
[12] Y. Nagata,et al. A multi-centre, retrospective case series of oocyte cryopreservation in unmarried women diagnosed with haematological malignancies , 2021, Human reproduction open.
[13] A. Neuraz,et al. Efficacy of assisted reproductive technology after ovarian tissue transplantation in a cohort of 11 patients with or without associated infertility factors , 2021, Journal of Assisted Reproduction and Genetics.
[14] F. Amant,et al. ESHRE guideline: female fertility preservation† , 2020, Human reproduction open.
[15] J. Donnez,et al. Fertility preservation in women for medical and social reasons: Oocytes vs ovarian tissue. , 2020, Best practice & research. Clinical obstetrics & gynaecology.
[16] P. Humaidan,et al. Reproductive outcomes after in vitro fertilization treatment in a cohort of Danish women transplanted with cryopreserved ovarian tissue. , 2020, Fertility and sterility.
[17] Lifeng Lin,et al. Meta-analysis of Proportions Using Generalized Linear Mixed Models , 2020, Epidemiology.
[18] J. Bergh,et al. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer—a prospective nationwide Swedish multicenter study , 2020, Human reproduction.
[19] Z. Nagy,et al. Vitrification of the human embryo: a more efficient and safer in vitro fertilization treatment. , 2020, Fertility and sterility.
[20] M. Gissler,et al. Trends in the incidence, rate and treatment of miscarriage-nationwide register-study in Finland, 1998-2016. , 2019, Human reproduction.
[21] C. Ronchetti,et al. Oocyte Cryopreservation in Oncological Patients: Eighteen Years Experience of a Tertiary Care Referral Center , 2019, Front. Endocrinol..
[22] L. Pazart,et al. Development of Ovarian Tissue Autograft to Restore Ovarian Function: Protocol for a French Multicenter Cohort Study , 2019, JMIR research protocols.
[23] C. Genestie,et al. Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantation. , 2019, Human reproduction.
[24] M. Montag,et al. Overnight ovarian tissue transportation for centralized cryobanking: a feasible option. , 2019, Reproductive biomedicine online.
[25] L. Rienzi,et al. A brief history of oocyte cryopreservation: Arguments and facts , 2019, Acta obstetricia et gynecologica Scandinavica.
[26] J. Remohi,et al. Elective and Onco-fertility preservation: factors related to IVF outcomes , 2018, Human reproduction.
[27] Yuting Fan,et al. Cryopreservation and transplantation of ovarian tissue: results from one center in the USA , 2018, Journal of Assisted Reproduction and Genetics.
[28] J. Remohi,et al. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. , 2018, Fertility and sterility.
[29] Kristin N. Smith,et al. Long-term outcomes in cancer patients who did or did not pursue fertility preservation. , 2018, Fertility and sterility.
[30] R. Álvarez,et al. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response , 2016, Human reproduction.
[31] M. Ignatiadis,et al. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[32] V. Tjan-Heijnen,et al. Abstract PD6-03: Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience , 2017 .
[33] L. Esserman,et al. Fertility preservation with ovarian stimulation and time to treatment in women with stage II–III breast cancer receiving neoadjuvant therapy , 2017, Breast Cancer Research and Treatment.
[34] M. Hernán,et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.
[35] S. Aviel-Ronen,et al. Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria. , 2016, Fertility and sterility.
[36] Morton B. Brown,et al. Embryo banking among women diagnosed with cancer: a pilot population-based study in New York, Texas, and Illinois , 2016, Journal of Assisted Reproduction and Genetics.
[37] M. Dolmans,et al. Utilization rates and results of long-term embryo cryopreservation before gonadotoxic treatment , 2015, Journal of Assisted Reproduction and Genetics.
[38] G. Bedoschi,et al. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] A. Pellicer,et al. Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer. , 2014, Reproductive biomedicine online.
[40] Y. Englert,et al. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis. , 2014, Human reproduction.
[41] J. Donnez,et al. Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes , 2014, Journal of Ovarian Research.
[42] D. de Ziegler,et al. Emergency IVF for embryo freezing to preserve female fertility: a French multicentre cohort study. , 2013, Human reproduction.
[43] K. J. Thong,et al. Fifteen year follow-up of embryos cryopreserved in cancer patients for fertility preservation , 2013, Journal of Assisted Reproduction and Genetics.
[44] A. Pellicer,et al. Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications. , 2013, Fertility and sterility.
[45] Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. , 2019, Fertility and sterility.
[46] K. Oktay,et al. Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer? , 2012, Fertility and sterility.
[47] J. Goldman,et al. Uptake and outcome of assisted reproductive techniques in long-term survivors of SCT , 2012, Bone Marrow Transplantation.
[48] C. Farquhar,et al. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. , 2012, The Cochrane database of systematic reviews.
[49] S. Missmer,et al. Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy. , 2011, Fertility and sterility.
[50] Wolfgang Viechtbauer,et al. Conducting Meta-Analyses in R with the metafor Package , 2010 .
[51] A. Stang. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.
[52] K. Oktay,et al. Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience. , 2010, Fertility and sterility.
[53] E. Porcu,et al. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. , 2009, Reproductive biomedicine online.
[54] Douglas G. Altman,et al. Chapter 9: Analysing Data and Undertaking Meta-Analyses , 2008 .
[55] L. Gianaroli,et al. Birth following vitrification of a small number of human oocytes: case report. , 1999, Human reproduction.